1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Journal Article (4957)
  2. Meeting Abstract (2007)
  3. Book Section (216)
  4. Conference Paper (122)
  5. Review (79)
  6. Editorial (48)
  7. Book Whole (28)
  8. Research Letter (15)
  9. Correspondence (8)
  10. Miscellaneous (6)
  11. Guidelines (1)
Groups
  1. Molecular Pharmacology and Chemistry Program Faculty (7487)
  2. Sloan Kettering Institute Faculty (7487)
  3. GSK Faculty (4697)
  4. Department of Medicine (2717)
  5. Surgery (2096)
  6. Center for Hematologic Malignancies (1819)

More Groups

People
  1. Murray Brennan (1059)
  2. Steven Larson (957)
  3. Peter Scardino (671)
  4. Michel Sadelain (582)
  5. Samuel Danishefsky (539)
  6. David Scheinberg (499)

More People

Years
  1. 2025 (36)
  2. 2024 (94)
  3. 2023 (122)
  4. 2022 (150)
  5. 2021 (154)
  6. 2020 (162)

More Years

Publications
  1. Journal of Nuclear Medicine (382)
  2. Blood (379)
  3. Cancer Research (340)
  4. Journal of Clinical Oncology (315)
  5. Annals of Surgical Oncology (181)
  6. International Journal of Radiation Oncology, Biology, Physics (176)

More Publications

Publishers
  1. American Association for Cancer Research (712)
  2. Elsevier Inc. (693)
  3. Nature Publishing Group (490)
  4. Springer (467)
  5. American Chemical Society (440)
  6. Elsevier Science, Inc. (405)

More Publishers

Results (7487)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Analysis of 154 actual 5-year survivors in gastric cancer
    Meeting Abstract

    Hochwald, S. N.; Kim, S.; Klimstra, D.; Brennan, M. F.; Karpeh, M.
    Gastroenterology (1999)

    Fulltext@MSK | Save
  • K-ras mutation and prognosis in pancreatic adeno-carcinoma
    Meeting Abstract

    Paty, P. B.; Nakayama, T.; Conlon, K. C.; Klimstra, D. S.; Zakowski, M.; Brennan, M. F.; Barany, F.
    Gastroenterology (1999)

    Fulltext@MSK | Save
  • ATM inhibits DNA damage-induced apoptosis via ceramide synthase
    Meeting Abstract

    Liao, W. C.; Haimovitz-Friedman, A.; Persaud, R. S.; McLoughlin, M.; Ehleiter, D.; Zhang, N.; Lavin, M.; Kolesnick, R.; Fuks, Z.
    FASEB Journal (1999)

    Fulltext@MSK | Save
  • Fractionated radioimmunotherapy with I-131 chimeric antibody G250 (cG250) in metastatic renal cancer
    Meeting Abstract

    Divgi, C. R.; O'Donoghue, J. A.; McGagh, D.; Anwar, K.; Motzer, R.; Welt, S.; Larson, S. M.; Old, L. J.
    European Journal of Nuclear Medicine (1999)

    Fulltext@MSK | Save
  • A comparison of reconstruction algorithms with FDG-PET: Iterative reconstruction segmented attenuation correction (IRSAC) allows greater lesion detectability than filtered back projection (FBP)
    Meeting Abstract

    Akhurst, T.; Erdi, Y.; Macapinlac, H.; Humm, J.; Yeung, H.; Larson, S. M.
    European Journal of Nuclear Medicine (1999)

    Fulltext@MSK | Save
  • A comparison of reconstruction algorithms with FDG-PET: Iterative reconstruction segmented attenuation correction (IRSAC) allows greater lesion detectability than filtered back projection (FBP)
    Meeting Abstract

    Akhurst, T.; Erdi, Y.; Macapinlac, H.; Humm, J.; Yeung, H.; Larson, S. M.
    European Journal of Nuclear Medicine (1999)

    Fulltext@MSK | Save
  • Conformal radiotherapy for prostate cancer
    Meeting Abstract

    Fuks, Z.
    European Journal of Cancer (1999)

    Fulltext@MSK | Save
  • A comparison of reconstruction algorithms with FDG PET. Iterative reconstruction segmented attenuation correction (IRSAC) allows greater detectability than filtered back projection (FBP)
    Meeting Abstract

    Akhurst, T.; Erdi, Y.; Colsher, J.; Crandall, P.; MacApinlac, H.; Humm, J.; Yeung, H.; Larson, S. M.
    European Journal of Nuclear Medicine (1999)

    Fulltext@MSK | Save
  • [F-18]2-fluoro-2-doxyglucose (FDG) and C-11-methionine (C-11 MET) positron emission tomography (PET) versus conventional imaging modalities (CIM) in patients with newly progressing metastatic prostate cancer
    Meeting Abstract

    Nunez, R.; Macapinlac, H.; Yeung, H. W. D.; Akhurst, T.; Finn, R. D.; Osman, I.; Petrisko, R.; Scher, H. I.; Larson, S. M.
    European Journal of Nuclear Medicine (1999)

    Fulltext@MSK | Save
  • The Hsp90 chaperone system as a potential therapeutic target: Identification of a geldanamycin dimer that induces the selective degradation of HER-family tyrosine kinases
    Meeting Abstract

    Zheng, F. Z. F.; Mùˆnster, P. N.; Kuduk, S.; Danishefsky, S.; Sepp-Lorenzino, L.; Rosen, N.
    Clinical Cancer Research (1999)

    Fulltext@MSK | Save